This is a demo store. No orders will be fulfilled.

Recombinant Human EGF Protein, >95% SDS-PAGE, high purity

Features and benefits
  • Expression System: Pichia pastoris
  • Accession #: P01133
  • Protein Tag: No tag
  • Bioactivity: Measured in a cell proliferation assay using BALB/3T3 mouse embryo fibroblasts cell line. The ED₅₀ for this effect is typically <0.9 ng/mL.
  • Endotoxin Concentration: <0.2 EU/μg
In stock
Item Number
rp145392
Grouped product items
SKUSizeAvailabilityPrice Qty
rp145392-100μg
100μg
7
$69.90
rp145392-1mg
1mg
8
$399.90
rp145392-500μg
500μg
10
$299.90

GMP, ≥95% (SDS-PAGE), Active, Pichia pastoris, No tag, 971-1021aa

Basic Description

Product NameRecombinant Human EGF Protein, >95% SDS-PAGE, high purity
Synonymsbeta-urogastrone | EGF | epidermal growth factor (beta-urogastrone) | epidermal growth factor | hEGF | HOMG4 | pro-epidermal growth factor | URG | Urogastrone | EGF
GradeActiBioPure™, Animal Free, Bioactive, Carrier Free, GMP, High Performance
Specifications & PurityCarrier Free, GMP, Bioactive, ActiBioPure™, High Performance, Animal Free, ≥95%(SDS-PAGE)
Biochemical and Physiological MechanismsEGF stimulates the growth of various epidermal and epithelial tissues in vivo and in vitro and of some fibroblasts in cell culture. Magnesiotropic hormone that stimulates magnesium reabsorption in the renal distal convoluted tubule via engagement of EGFR
Purity>95% SDS-PAGE
BioactivityMeasured in a cell proliferation assay using BALB/3T3 mouse embryo fibroblasts cell line. The ED₅₀ for this effect is typically <0.9 ng/mL.
Endotoxin Concentration<0.2 EU/μg
Expression SystemPichia pastoris
SpeciesHuman
Amino Acids971-1021 aa
SequenceNSDSECPLSHDGYCLHDGVCMYIEALDKYACNCVVGYIGERCQYRDLKWWE
Protein TagNo tag
Protein LengthFull length protein
Accession #P01133
SourceRecombinant
Predicted molecular weight6 kDa

Images

Recombinant Human EGF Protein (rp145392)-Protein Bioactivity
Measured in a cell proliferation assay using BALB/3T3 mouse embryo fibroblasts cell line. The ED₅₀ for this effect is typically <0.9ng/mL.

Recombinant Human EGF Protein (rp145392)-SDS-PAGE
5μg/lane of Recombinant Human EGF was resolved with SDS-PAGE under reducing (R) and non-reducing (N) conditions and visualized by Coomassie® Blue staining, showing a single band at 6.6 kDa.

Product Specifications

ShapeLyophilized
ReconstitutionWe recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile 10mM PBS to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 ℃. Further dilutions should be made in appropriate buffered solutions.
Storage TempStore at -20°C,Avoid repeated freezing and thawing
Shipped InIce chest + Ice pads
Stability And StorageStore at 2-8℃ short term (4 weeks). Store at -20℃ long term (24 months). Upon reconstitution, it is recommended to aliquot. Avoid freeze/thaw cycle.
CAS62253-63-8

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

3 results found

Lot NumberCertificate TypeDateItem
ZJ23F0400094Certificate of AnalysisApr 25, 2023 rp145392
ZJ23F0400095Certificate of AnalysisApr 25, 2023 rp145392
ZJ23F0400093Certificate of AnalysisApr 19, 2023 rp145392

Safety and Hazards(GHS)

Pictogram(s) GHS07
Signal Warning
Hazard Statements

H315:Causes skin irritation

H319:Causes serious eye irritation

H335:May cause respiratory irritation

Precautionary Statements

P261:Avoid breathing dust/fume/gas/mist/vapors/spray.

P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352:IF ON SKIN: wash with plenty of water.

P321:Specific treatment (see ... on this label).

P405:Store locked up.

P501:Dispose of contents/container to ...

P264:Wash hands [and …] thoroughly after handling.

P271:Use only outdoors or in a well-ventilated area.

P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing.

P403+P233:Store in a well-ventilated place. Keep container tightly closed.

P362+P364:Take off contaminated clothing and wash it before reuse.

P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes.

P337+P317:If eye irritation persists: Get medical help.

P332+P317:If skin irritation occurs: Get medical help.

P319:Get medical help if you feel unwell.

WGK Germany 3

Specifications

Alternative Products

Citations of This Product

1. Xiaoli Lu, Shangwen Sun, Na Li, Shuying Hu, Yuyao Pan, Lin Wang, Xuefeng Zhou, Hanbang Chen, Feimin Zhang.  (2024)  Janus sponge/electrospun fibre composite combined with EGF/bFGF/CHX promotes reconstruction in oral tissue regeneration.  COLLOIDS AND SURFACES B-BIOINTERFACES,  243  (114117).  [PMID:39084056] [10.1016/j.colsurfb.2024.114117]

References

1. Ogiso H, Ishitani R, Nureki O, Fukai S, Yamanaka M, Kim JH, Saito K, Sakamoto A, Inoue M, Shirouzu M et al..  (2002)  Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains..  Cell,  110  (6): (775-87).  [PMID:12297050] [10.1021/op500134e]
2. Feng Y, Yin Y, Weiser A, Griffin E, Cameron MD, Lin L, Ruiz C, Schürer SC, Inoue T, Rao PV, Schröter T, Lograsso P..  (2008)  Discovery of substituted 4-(pyrazol-4-yl)-phenylbenzodioxane-2-carboxamides as potent and highly selective Rho kinase (ROCK-II) inhibitors..  J Med Chem,  51  (21): (6642-6645).  [PMID:18834107] [10.1021/jm800986w]
3. Lesuisse D, Mauger J, Nemecek C, Maignan S, Boiziau J, Harlow G, Hittinger A, Ruf S, Strobel H, Nair A, Ritter K, Malleron JL, Dagallier A, El-Ahmad Y, Guilloteau JP, Guizani H, Bouchard H, Venot C..  (2011)  Discovery of the first non-ATP competitive IGF-1R kinase inhibitors: advantages in comparison with competitive inhibitors..  Bioorg Med Chem Lett,  21  (8): (2224-2228).  [PMID:21441024] [10.1016/j.bmcl.2011.03.003]
4. Hodgetts KJ, Ge P, Yoon T, De Lombaert S, Brodbeck R, Gulianello M, Kieltyka A, Horvath RF, Kehne JH, Krause JE, Maynard GD, Hoffman D, Lee Y, Fung L, Doller D..  (2011)  Discovery of N-(1-ethylpropyl)-[3-methoxy-5-(2-methoxy-4-trifluoromethoxyphenyl)-6-methyl-pyrazin-2-yl]amine 59 (NGD 98-2): an orally active corticotropin releasing factor-1 (CRF-1) receptor antagonist..  J Med Chem,  54  (12): (4187-4206).  [PMID:21618986] [10.1021/jm200365y]
5. Gregory, H H and Preston, B M BM..  (1977)  The primary structure of human urogastrone..  International journal of peptide and protein research,      [PMID:300079]
6. Hommel, U U, Harvey, T S TS, Driscoll, P C PC and Campbell, I D ID..  (1992)  Human epidermal growth factor. High resolution solution structure and comparison with human transforming growth factor alpha..  Journal of molecular biology,    (5):   [PMID:1522591]
7. Furuya, M M, Akashi, S S and Hirayama, K K..  (1989)  The primary structure of human EGF produced by genetic engineering, studied by high-performance tandem mass spectrometry..  Biochemical and biophysical research communications,    (15):   [PMID:2789514]
8. Bell, G I GI and 8 more authors..  (1986)  Human epidermal growth factor precursor: cDNA sequence, expression in vitro and gene organization..  Nucleic acids research,    (11):   [PMID:3491360]
9. Lu, H S HS and 5 more authors..  (2001)  Crystal structure of human epidermal growth factor and its dimerization..  The Journal of biological chemistry,    (14):   [PMID:11438527]
10. Ferguson, Kathryn M KM and 5 more authors..  (2003)  EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization..  Molecular cell,      [PMID:12620237]
11. Hillier, Ladeana W LW and 121 more authors..  (2005)  Generation and annotation of the DNA sequences of human chromosomes 2 and 4..  Nature,    (7):   [PMID:15815621]
12. Groenestege, Wouter M Tiel WM and 10 more authors..  (2007)  Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia..  The Journal of clinical investigation,      [PMID:17671655]
13. Lu, Chafen C and 6 more authors..  (2010)  Structural evidence for loose linkage between ligand binding and kinase activation in the epidermal growth factor receptor..  Molecular and cellular biology,      [PMID:20837704]
14. Huang, Hsiao-Wen HW, Mohan, Sepuru K SK and Yu, C C..  (2010)  The NMR solution structure of human epidermal growth factor (hEGF) at physiological pH and its interactions with suramin..  Biochemical and biophysical research communications,    (26):   [PMID:21029725]
15. Zettl, Markus M, Adrain, Colin C, Strisovsky, Kvido K, Lastun, Viorica V and Freeman, Matthew M..  (2011)  Rhomboid family pseudoproteases use the ER quality control machinery to regulate intercellular signaling..  Cell,    (1):   [PMID:21439629]
16. Xiaoli Lu, Shangwen Sun, Na Li, Shuying Hu, Yuyao Pan, Lin Wang, Xuefeng Zhou, Hanbang Chen, Feimin Zhang.  (2024)  Janus sponge/electrospun fibre composite combined with EGF/bFGF/CHX promotes reconstruction in oral tissue regeneration.  COLLOIDS AND SURFACES B-BIOINTERFACES,  243  (114117).  [PMID:39084056] [10.1016/j.colsurfb.2024.114117]

Solution Calculators

Reviews

Customer Reviews